These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 6970037)
21. [Pharmacologic profile of a new compound with antiinflammatory activity: 2-(4-dimethylvinylphenyl)propionic acid (Gx 258)]. Bossoni G; Coppi G; Lumachi B; Milanino R; Passarella E; Toson G; Valsecchi B Farmaco Sci; 1984 May; 39(5):421-9. PubMed ID: 6610567 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions. Tsurumi K; Kyuki K; Niwa M; Mibu H; Fujimura H Arzneimittelforschung; 1986 Dec; 36(12):1801-5. PubMed ID: 3105545 [TBL] [Abstract][Full Text] [Related]
23. Some aspects of the pharmacology of butibufen, a non-steroidal anti-inflammatory agent. Aparicio L Arch Int Pharmacodyn Ther; 1977 May; 227(1):130-41. PubMed ID: 901061 [TBL] [Abstract][Full Text] [Related]
24. 1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties. Dajani EZ; Larsen KR; Taylor J; Dajani NE; Shahwan TG; Neeleman SD; Taylor MS; Dayton MT; Mir GN J Pharmacol Exp Ther; 1999 Oct; 291(1):31-8. PubMed ID: 10490883 [TBL] [Abstract][Full Text] [Related]
25. The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic agent. Adams SS; McCullough KF; Nicholson JS Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):115-29. PubMed ID: 5353466 [No Abstract] [Full Text] [Related]
26. [The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals]. Amanuma F; Okuyama S; Orikasa S; Hashimoto S; Yamada C; Sakagawa T; Tsutsui Y; Tarumoto Y; Aihara H; Kameyama T Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):345-54. PubMed ID: 6611288 [TBL] [Abstract][Full Text] [Related]
27. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties. Zwagemakers JM; Claassen V Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021 [TBL] [Abstract][Full Text] [Related]
28. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide. Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a new anti-inflammatory/analgesic compound F-776, 5-(4-chlorophenyl)-beta-hydroxy-2-furanpropanoic acid. Goldenberg MM; Boise KL; Ilse AC Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):331-50. PubMed ID: 6966489 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological study of the new nonsteroidal antiinflammatory agent 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate. Ucelay M; Lasheras B; Cenarruzabeitia E Arzneimittelforschung; 1988 Apr; 38(4):546-51. PubMed ID: 3401269 [TBL] [Abstract][Full Text] [Related]